2018
DOI: 10.1101/393876
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Suppression of p16 induces mTORC1-mediated nucleotide metabolic reprogramming

Abstract: 2 SummaryReprogrammed metabolism and cell cycle dysregulation are two cancer hallmarks. p16 is a cell cycle inhibitor and tumor suppressor that is upregulated during oncogeneinduced senescence (OIS). Loss of p16 allows for uninhibited cell cycle progression, bypass of OIS, and tumorigenesis. Whether p16 loss affects pro-tumorigenic metabolism is unclear. We report that suppression of p16 plays a central role in

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
16
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
3

Relationship

3
4

Authors

Journals

citations
Cited by 10 publications
(17 citation statements)
references
References 91 publications
1
16
0
Order By: Relevance
“…1A-E), a classical model of OIS [5,61]. The shRNA hairpin specificity targeting p16 was previously validated [8]. Similar results were observed in normal skin fibroblasts Hs 895.Sk (Fig.…”
Section: Knockdown Of P16 Abrogates Oncogene-induced Il6 and Cxcl8 Exsupporting
confidence: 77%
See 1 more Smart Citation
“…1A-E), a classical model of OIS [5,61]. The shRNA hairpin specificity targeting p16 was previously validated [8]. Similar results were observed in normal skin fibroblasts Hs 895.Sk (Fig.…”
Section: Knockdown Of P16 Abrogates Oncogene-induced Il6 and Cxcl8 Exsupporting
confidence: 77%
“…Canonically, elevated p16 represses hyperphosphorylation of the retinoblastoma protein (RB), which inhibits E2F transcription factor-mediated expression of proliferative genes [7]. Loss of p16 is a common event in human cancer that has been linked to senescence bypass, increased proliferation, and malignant transformation though both canonical and non-canonical (RB-independent) pathways [8][9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…To achieve sustainable long-term growth, oncogene-driven malignancies need to maintain sufficient dNTP pools, and this can be achieved through metabolic rewiring. This has been demonstrated in the case of oncogenic BRAF (19) and KRAS-driven PAAD (20), which upregulate de novo dNTP synthesis via the pentose phosphate pathway. Our analysis of clinical data suggests downregulation of dNTP catabolism via SAMHD1 could be an important component of this rewiring.…”
Section: Figure 1 Samhd1 Limits the Proliferation Of Cells Harbourinmentioning
confidence: 90%
“…Cells were routinely tested for mycoplasma as described in (27). Experiments targeting Ribonucleotide Reductase Regulatory Subunit M2 (RRM2), p16, mammalian target of rapamycin (mTOR), and ATR serine/threonine kinase (ATR) were previously included in Buj, et al (28). Lentiviral constructs were transfected into 293FT cells using Lipofectamine 2000 (Thermo Fisher, Cat# 11668019).…”
Section: Cell Culturementioning
confidence: 99%
“…To examine the effect of isotope dilution versus label free quantification we analyzed data from IMR90 cells with various short hairpin knockdown of genes found to disrupt nucleotide metabolism (28). This provided a bioanalytical meaningful way to modulate dNTP metabolites within similar cellular backgrounds.…”
Section: Stable Isotope Dilution Improves Analytical Performance Of Lmentioning
confidence: 99%